United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54348-819_eaa5779b-4250-01ba-e053-2a95a90ae500
- Product NDC
- 54348-819
- Form
- TABLET, FILM COATED
- Composition / generic term
- ONDANSETRON
- Labeler
- PharmPak, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190710
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 BOX (54348-819-00) / 1 TABLET, FILM COATED in 1 BOTTLE · 54348-819-00
- 1 BOTTLE in 1 BOX (54348-819-02) / 2 TABLET, FILM COATED in 1 BOTTLE · 54348-819-02
- 1 BOTTLE in 1 BOX (54348-819-04) / 4 TABLET, FILM COATED in 1 BOTTLE · 54348-819-04
- 1 BOTTLE in 1 BOX (54348-819-06) / 6 TABLET, FILM COATED in 1 BOTTLE · 54348-819-06
- 1 BOTTLE in 1 BOX (54348-819-08) / 8 TABLET, FILM COATED in 1 BOTTLE · 54348-819-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →